Literature DB >> 26362843

Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.

Hèctor Corominas1, Javier Narváez2, César Díaz-Torné3, Georgina Salvador4, María Eugenia Gomez-Caballero5, Diana de la Fuente6, Ester Campoy7, Daniel Roig-Vilaseca8, Teresa Clavaguera9, Rosa Morlà10, Vicenç Torrente-Segarra8, Xavier Arasa11, José Alfredo Gomez-Puerta5, Ingrid Möller12, Cayetano Alegre13, Eduard Graell14, Andrés Ponce15, María Pilar Lisbona16, Carolina Pérez-Garcia17, Ramon Fíguls8, Elena Sirvent18, Violan Poca19, Raimon Sanmartí5.   

Abstract

OBJECTIVE: Diagnosis and therapy of patients with early onset rheumatoid arthritis (RA) is influenced by accessibility to specialized care devices. We attempted to analyze the impact of their availability.
METHODS: We analyzed time related to diagnosis delay measuring: 1) Time from first clinical symptoms to the first visit with the Rheumatologist; 2) Time from referral to the first visit of Rheumatology; 3) Time between first symptom until final diagnosis; 4) time between first symptom until the initiation of the first disease-modifying antirheumatic drug (DMARD). The presence of these 6 rheumatology devices was defined: 1) early arthritis monographic clinics, 2) RA monographic clinics, 3) Mechanisms for fast programming, 4) Algorithms for referral from primary care (PC), 5) rheumatology consultation services in PC and 6) consulting services in PC.
RESULTS: The mean time from onset of symptoms to diagnosis or the establishment of a DMARD in RA patients in Catalonia is very long (11 months). Patients seen in rheumatology devices such as RA monographic clinics, rheumatology consultation in PC and specially in early arthritis clinics are treated early with DMARDs.
CONCLUSION: the existence of monographic clinics or consulting in primary care centers is essential to improve early care of RA patients.
Copyright © 2015 Elsevier España, S.L.U. y Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  AUDIT study; Artritis reumatoide de inicio reciente; Dispositivos de asistenciales especializados; Early onset rheumatoid arthritis; Estudio AUDIT; Health care devices

Mesh:

Substances:

Year:  2015        PMID: 26362843     DOI: 10.1016/j.reuma.2015.08.002

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  4 in total

1.  [ADAPTHERA-Statewide cross-sectoral care network for patients with early rheumatoid arthritis shows sustained remission in standard care].

Authors:  A Lauter; K Triantafyllias; R Leiß; C Amberger; J Engels; M Hesse; M Jendro; J Gilly; M-L Stadelmann; W Ziese; D Wollschläger; M Dreher; B Pfeiff; J Weinmann-Menke; T Panholzer; A Schwarting
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

2.  Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis.

Authors:  Carlos Ríos; Génessis Maldonado; Carlos Paredes; Christian Ferro; Mario Moreno; Claudia Vera; Sara Vargas; Wendy Calapaqui; Carlos Vallejo
Journal:  Open Access Rheumatol       Date:  2017-06-13

3.  Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort.

Authors:  L Ellingwood; O Schieir; M F Valois; S J Bartlett; L Bessette; G Boire; G Hazlewood; C Hitchon; E C Keystone; D Tin; C Thorne; V P Bykerk; J E Pope
Journal:  ACR Open Rheumatol       Date:  2019-10-21

4.  Journey of rheumatoid arthritis patients in Tunisia: From symptoms to treatment.

Authors:  Alia Fazaa; Hiba Bettaieb; Meriem Sellami; Saoussen Miladi; Kmar Ouenniche; Leila Souebni; Selma Kassab; Selma Chekili; Leith Zakraoui; Kaouther Abdelghani; Ahmed Laatar
Journal:  Arch Rheumatol       Date:  2021-10-13       Impact factor: 1.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.